The First EASL NAFLD Summit: Diagnosis and pharmacotherapy of NASH 2017 covers topics such as:
Patient management
NAFLD pathogenesis
Non-invasive assessment of fibrosis
Prognostic and therapeutic targets
Biomarkers
Apoptosis
Hormonal and bile acids signalling
Insulin resistance and signalling
Inflammation and immunity in NASH
Oxidative and mitochondrial stress
Gut microbiota
Carcinogenesis
The First EASL NAFLD Summit: Diagnosis and pharmacotherapy of NASH 2017 brings together:
Clinical researchers
Basic and translational scientists
Hepatologists
Industry / Biotechnology
Regulatory and funding agencies
Health professionals
Young researchers and trainees
Past Events
First EASL NAFLD Summit: Diagnosis and pharmacotherapy of NASH 2017 - 09-11 Nov 2017, Radisson Blu es. Hotel, Roma, Italy (68212)
Important
Please, check "EASL NAFLD Summit: Diagnosis and pharmacotherapy of NASH" official website for possible changes, before making any traveling arrangements
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.